Version 2.78

Term Description

This subsection, which is contained in the Use in Specific Populations section, describes the use of the product in patients with hepatic impairment, according to the Physical Labeling Rule format. [https://www.fda.gov/OHRMS/DOCKETS/98fr/06-545.pdf]
Source: Regenstrief LOINC

Fully-Specified Name

Component
Hepatic Impairment subsection
Property
-
Time
-
System
^FDA package insert
Scale
Nar
Method

Additional Names

Long Common Name
FDA package insert Hepatic Impairment subsection
Short Name
FDA insert Hepatic Impairment subsection

Basic Attributes

Class
DOC.REF
Type
Clinical
First Released
Version 2.64
Last Updated
Version 2.64
Order vs. Observation
Both

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Subsección de insuficiencia hepática:-:-:^ Prospecto de la FDA:Narrativo:
it-IT Italian (Italy) Compromissione epatica, sottosezione:-:-:^FDA, foglio illustrativo:Nar:
Synonyms: Documentazione di riferimento Foglio illustrativo della Food and Drug Administra Sottosezione di compromissione epatica
zh-CN Chinese (China) 肝脏损害子节:-:-:^FDA 包装说明书:叙述型:
Synonyms: SPL;结构化产品标签;结构化产品标签;Structured Product Labelling;结构化产品标记;结构化产品标识;美国食品及药品管理局包装说明书;超系统 - FDA 包装说明书;食品及药品管理局包装说明书;FDA 包装插页 参考文件;参考文档;引用文件;引用文档;文件.参考;文件.引用;文档.引用 叙述;叙述性文字;报告;报告型;文字叙述;文本叙述型;文本描述;文本描述型 肝脏（肝、肝脏功能、肝功能）损害（损伤）子节（子小节、小节）

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=88829-7